source
- Parabilis raises record $670 million in biotech IPO, the largest for a venture-backed companyParabilis Medicines, a biotech focused on "undruggable" targets, completed an initial public offering that raised $670 million, the biggest amount ever for a venture-backed biotech. The company so…
- Sanofi halts Phase 3 trial of riliprubart in CIDP after interim analysis shows unlikely efficacySanofi announced Wednesday that it is stopping the Phase 3 MOBILIZE study of its experimental anti‑inflammatory drug riliprubart in patients with chronic inflammatory demyelinating polyneuropathy (…